Literature DB >> 22139597

Surgical response to the 2008 Mumbai terror attack.

A H Bhandarwar1, G D Bakhshi, M B Tayade, A D Borisa, N R Thadeshwar, S S Gandhi.   

Abstract

BACKGROUND: Mumbai, the financial capital of India, was attacked by terrorists at various famous, densely populated places on 26 November 2008. The attack lasted for 60 h, resulting in multiple civilian casualties from bullet and blast injuries. The aim was to review the disaster management plan and analyse the injury patterns and surgical response.
METHODS: The disaster management plan was activated in the Sir Jamshetjee Jejeebhoy Group of Hospitals as soon as the earliest casualties were reported. The casualty receiving area was converted into a triage zone; patients were accordingly sent to different stations for further management. There was rotation of the duties of the medical personnel every 8 h for increased efficiency.
RESULTS: A total of 271 casualties were encountered, of which 108 were dead at admission. Some 163 patients were triaged, 23 of whom received primary care as outpatients. The remaining 140 patients needed admission to hospital; 194 operations were performed in 127 patients. There were six postoperative deaths.
CONCLUSION: This was a unique terrorist attack targeted on civilians and continuing for more than 2 days. The casualties consisted of military injuries due to combined firearm and blast trauma. Primary triage, or onsite triage once the site is safe, optimizes management.
Copyright © 2011 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 22139597     DOI: 10.1002/bjs.7738

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  1 in total

Review 1.  26/11 Mumbai terrorist attack revisited: Lessons learnt and novel disaster model for future.

Authors:  Dhiraj V Sonawane; Bipul K Garg; Ajay Chandanwale; Ambarish A Mathesul; Omkar R Shinde; Shravan Singh
Journal:  Jamba       Date:  2020-08-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.